Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

1. Rueda, A.
2. Calvo, V.
3. Casanova, M.
4. Rodriguez-Abreu, D.
5. Aguiar, D.
6. Llanos, M.
7. Alvarez, R.
8. Martinez-Banaclocha, N.
9. Alfaro, J.
10. Quero, C.
11. Blasco, A.
12. de la Cruz Merino, L.
13. Herrero, J.
14. García-Arroyo, F.R.
15. Provencio, M.